Center-Authored Papers

Filters: Author is McIntosh, Martin W  [Clear All Filters]
2003
Etzioni R, Urban ND, Ramsey S, McIntosh M, Schwartz S, Reid B, Radich J, Anderson G, Hartwell L.  2003.  The case for early detection.. Nature reviews. Cancer. 3(4):243-52. Abstract
2008
Faça VM, Ventura AP, Fitzgibbon MP, Pereira-Faça SR, Pitteri SJ, Green AE, Ireton RC, Zhang Q, Wang H, O'Briant KC et al..  2008.  Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains.. PloS one. 3(6):e2425. Abstract
Palmer C, Duan X, Hawley S, Scholler N, Thorpe JD, Sahota RA, Wong MQ, Wray A, Bergan LA, Drescher CW et al..  2008.  Systematic evaluation of candidate blood markers for detecting ovarian cancer.. PloS one. 3(7):e2633. Abstract
Scholler N, Gross JA, Garvik B, Wells L, Liu Y, Loch CM, Ramirez AB, McIntosh MW, Lampe PD, Urban ND.  2008.  Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery.. Journal of translational medicine. 6:41. Abstract
Pitteri SJ, Faca VM, Kelly-Spratt KS, Kasarda EA, Wang H, Zhang Q, Newcomb L, Krasnoselsky A, Paczesny S, Choi G et al..  2008.  Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.. Journal of proteome research. 7(4):1481-9. Abstract
May D, Liu Y, Law W, Fitzgibbon M, Wang H, Hanash S, McIntosh M.  2008.  Peptide sequence confidence in accurate mass and time analysis and its use in complex proteomics experiments.. Journal of proteome research. 7(12):5148-56. Abstract
Faca VM, Song KS, Wang H, Zhang Q, Krasnoselsky AL, Newcomb LF, Plentz RR, Gurumurthy S, Redston MS, Pitteri SJ et al..  2008.  A mouse to human search for plasma proteome changes associated with pancreatic tumor development.. PLoS medicine. 5(6):e123. Abstract
McIntosh MW, Anderson G, Drescher CW, Hanash SM, Urban ND, Brown P, Gambhir SS, Coukos G, Laird PW, Nelson B et al..  2008.  Ovarian cancer early detection claims are biased.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(22):7574;authorreply7577-9.
Lowe KA, Shah C, Wallace E, Anderson G, Paley P, McIntosh MW, Andersen MR, Scholler N, Bergan L, Thorpe J et al..  2008.  Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(9):2480-7. Abstract
2009
Pitteri SJ, Hanash SM, Aragaki A, Amon LM, Chen L, Busald Buson T, Paczesny S, Katayama H, Wang H, Johnson MM et al..  2009.  Postmenopausal estrogen and progestin effects on the serum proteome.. Genome medicine. 1(12):121. Abstract
Pan S, Chen R, Reimel BA, Crispin DA, Mirzaei H, Cooke K, Coleman JF, Lane Z, Bronner MP, Goodlett DR et al..  2009.  Quantitative proteomics investigation of pancreatic intraepithelial neoplasia.. Electrophoresis. 30(7):1132-44. Abstract
Reimel BA, Pan S, May DH, Shaffer SA, Goodlett DR, McIntosh MW, Yerian LM, Bronner MP, Chen R, Brentnall TA.  2009.  Proteomics on Fixed Tissue Specimens - A Review.. Current proteomics. 6(1):63-69. Abstract
Pan S, Aebersold R, Chen R, Rush J, Goodlett DR, McIntosh MW, Zhang J, Brentnall TA.  2009.  Mass spectrometry based targeted protein quantification: methods and applications.. Journal of proteome research. 8(2):787-97. Abstract
McIntosh MW, Fitzgibbon M.  2009.  Biomarker validation by targeted mass spectrometry.. Nature biotechnology. 27(7):622-3.
May D, Law W, Fitzgibbon M, Fang Q, McIntosh MW.  2009.  Software platform for rapidly creating computational tools for mass spectrometry-based proteomics.. Journal of proteome research. 8(6):3212-7. Abstract
Fang Q, Strand A, Law W, Faca VM, Fitzgibbon MP, Hamel N, Houle B, Liu X, May DH, Poschmann G et al..  2009.  Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease.. Molecular & cellular proteomics : MCP. 8(3):451-66. Abstract
Shah CA, Lowe KA, Paley P, Wallace E, Anderson GL, McIntosh MW, Andersen MR, Scholler N, Bergan LA, Thorpe JD et al..  2009.  Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(5):1365-72. Abstract
Brentnall TA, Pan S, Bronner MP, Crispin DA, Mirzaei H, Cooke K, Tamura Y, Nikolskaya T, JeBailey L, Goodlett DR et al..  2009.  Proteins That Underlie Neoplastic Progression of Ulcerative Colitis.. Proteomics. Clinical applications. 3(11):1326-1337. Abstract
2010
Schummer M, Green A, Beatty JD, Karlan BY, Karlan S, Gross J, Thornton S, McIntosh MW, Urban ND.  2010.  Comparison of breast cancer to healthy control tissue discovers novel markers with potential for prognosis and early detection.. PloS one. 5(2):e9122. Abstract
Chen R, Pan S, Duan X, Nelson BH, Sahota RA, de Rham S, Kozarek RA, McIntosh MW, Brentnall TA.  2010.  Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia.. Molecular cancer. 9:149. Abstract
Amon LM, Law W, Fitzgibbon MP, Gross JA, O'Briant K, Peterson A, Drescher CW, Martin DB, McIntosh MW.  2010.  Integrative proteomic analysis of serum and peritoneal fluids helps identify proteins that are up-regulated in serum of women with ovarian cancer.. PloS one. 5(6):e11137. Abstract
Prentice RL, Paczesny S, Aragaki A, Amon LM, Chen L, Pitteri SJ, McIntosh MW, Wang P, Buson Busald T, Hsia J et al..  2010.  Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling.. Genome medicine. 2(7):48. Abstract
Anderson GL, McIntosh MW, Wu LL, Barnett M, Goodman GE, Thorpe JD, Bergan L, Thornquist MD, Scholler N, Kim N et al..  2010.  Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.. Journal of the National Cancer Institute. 102(1):26-38. Abstract
Ramirez AB, Loch CM, Zhang Y, Liu Y, Wang X, Wayner EA, Sargent JE, Sibani S, Hainsworth E, Mendoza EA et al..  2010.  Use of a single-chain antibody library for ovarian cancer biomarker discovery.. Molecular & cellular proteomics : MCP. 9(7):1449-60. Abstract
Pitteri SJ, Amon LM, Busald Buson T, Zhang Y, Johnson MM, Chin A, Kennedy J, Wong C-H, Zhang Q, Wang H et al..  2010.  Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users.. Cancer research. 70(21):8598-606. Abstract